VBIV Vbi Vaccines Inc/Bc - 10-K
Filed Apr 16, 2024 for fiscal period ending Dec 31, 2023. See issuer overview · financials · original on SEC.gov ↗
Accession
0001493152-24-014744Signal
Mild positive shiftfull-docYoY shift: Neutral
Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K. This filing is 0.12pp more bullish than last year's.
Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.
Per-snippet highlights
Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.
No section text extracted for this filing. The 10-K may use a non-standard template that the parser doesn't recognize - the original doc is still linked in the Stats tab.
No section text extracted for this filing. The 10-K may use a non-standard template that the parser doesn't recognize - the original doc is still linked in the Stats tab.
Material contracts, certifications & more
14 exhibits filed with this 10-K
- Exhibit 10.62ex10-62.htm · 105.6 KB
- Exhibit 10.63ex10-63.htm · 105.9 KB
- Exhibit 10.64ex10-64.htm · 95.7 KB
- Exhibit 10.65ex10-65.htm · 97.5 KB
- Exhibit 10.66ex10-66.htm · 102.4 KB
- Exhibit 10.67ex10-67.htm · 95.7 KB
- Exhibit 10.68ex10-68.htm · 20.1 KB
- Exhibit 23.1: Consent of Independent Auditorsex23-1.htm · 4.9 KB
- Exhibit 31.1: Rule 13a-14(a) Certification (CEO)ex31-1.htm · 17.9 KB
- Exhibit 31.2: Rule 13a-14(a) Certification (CFO)ex31-2.htm · 18.0 KB
- Exhibit 32.1: Section 1350 Certification (CEO)ex32-1.htm · 5.6 KB
- Exhibit 32.2: Section 1350 Certification (CFO)ex32-2.htm · 5.9 KB
- Exhibit 97.1: Compensation Recovery Policyex97-1.htm · 46.8 KB
- 0001493152-24-014744-index-headers.html0001493152-24-014744-index-headers.html
- Ticker
- VBIV
- CIK
0000764195- Form Type
- 10-K
- Accession Number
0001493152-24-014744- Filed
- Apr 16, 2024
- Period
- Dec 31, 2023 (Q4 23)
- Industry
- Pharmaceutical Preparations
External resources
Permalink
https://insiderdelta.com/issuers/VBIV/10-k/0001493152-24-014744